Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Gemcitabine Hydrochloride for Injection

Approval Number

国药准字H20253258

Company四川百利药业有限责任公司

Registration Date

January 24, 2025

Drug Information

Generic Name

注射用盐酸吉西他滨

Dosage Form

注射剂

Strength

0.2g（按C₉H₁₁F₂N₃O₄ 计）

Drug Type

化学药品

Registration Date

January 24, 2025

Company Information

Applicant Company

Company Name四川百利药业有限责任公司

Company Address

成都市温江区成都海峡两岸科技产业开发园区

Manufacturing Company

Company Name成都百利多特生物药业有限责任公司

Company Address

成都市温江区成都海峡两岸科技产业开发园百利路139号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用盐酸吉西他滨 - NMPA 批准文号 | MedPath